Hsbc Holdings PLC Purchases 84,784 Shares of Sabra Healthcare REIT, Inc. $SBRA

Hsbc Holdings PLC lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 19.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 514,409 shares of the real estate investment trust’s stock after purchasing an additional 84,784 shares during the period. Hsbc Holdings PLC owned 0.20% of Sabra Healthcare REIT worth $9,738,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Rothschild Investment LLC grew its position in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the period. Smartleaf Asset Management LLC boosted its stake in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT in the third quarter worth $28,000. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT in the fourth quarter worth $29,000. Finally, Danske Bank A S bought a new stake in Sabra Healthcare REIT in the third quarter valued at $30,000. 99.40% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SBRA. Citigroup cut shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $24.00 to $19.00 in a research report on Monday. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Scotiabank dropped their price target on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Raymond James Financial began coverage on Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating on the stock. Finally, UBS Group set a $19.00 price objective on Sabra Healthcare REIT in a research note on Thursday, June 18th. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Hold” and a consensus price target of $21.30.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock opened at $19.54 on Friday. Sabra Healthcare REIT, Inc. has a 52 week low of $17.17 and a 52 week high of $21.28. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The business has a 50 day moving average price of $19.76 and a 200-day moving average price of $19.64. The company has a market cap of $4.93 billion, a PE ratio of 31.02, a price-to-earnings-growth ratio of 1.44 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the previous year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.